UCLA OIP-ISR logo

http://www.oip.ucla.edu/therapeutics  

THERAPEUTICS AND PHARMACEUTICALS


AUTOIMMUNE
  • 2012-140 A NOVEL APPROACH FOR ALLERGY THERAPEUTIC
  • 2011-776 Small Molecule Suppressors of Immune Function
  • 2008-799 Genomic Predictor of Kidney Cancer Prognosis and IL-2 Treatment Response
  • 2008-560 Reversing the Loss of Immune Function in Aged Populations Through the Induction of Antioxidant Activity by a Gene Regulatory Pathway
  • 2008-369 Fungal Immunosuppressive Compounds
  • 2008-211 Peptide for Induction of Immune Tolerance as Treatment for Systemic Lupus Erythematosus (SLE)
  • 2001-425 Receptor Interacting Protein 2 (RIP2) in Development of Immune Response
  • 1998-541 Specific Inhibitors of Cytokine Signaling
  • 1997-505 A Protein of Mycobacterium Tuberculosis Stimulates Interleukin-12 Production
  • 1991-543 Natural Killer Enhancing Factor

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    CARDIOVASCULAR
  • 2012-694 TREATING ATRIAL FIBRILATION BY TARGETING SUPEROXIDE PRODUCTION
  • 2011-417 A Small Molecule Inhibitor of Cholesterol Biosynthesis and Angiogenesis
  • 2010-769 Growth Factor Treatment of Myocardial Infarction
  • 2008-235 Genetic Engineering of Skeletal Muscle Cells for Autologous Cell Transplantations
  • 2006-397 HUMAN KUNITZ-TYPE INHIBITOR
  • 2001-429 5-Lipoxygenase, A New Therapeutic and Diagnostic Target for Heart Disease Management
  • 1996-592 Cerberus and FRZB-1, Secretory Molecules with a Regenerative Function and an Inhibitory Activity on WNTS, Respectively
  • 1996-528 Method and Device for Treating Intracranial Vascular Aneurysms
  • 1993-501 Organic Compounds for the Treatment of Myocardial Infarction
  • 1991-543 Natural Killer Enhancing Factor

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    DERMATOLOGY
  • 2012-558 Diagnosis and Personalized Acne Therapy
  • 2006-264 Nano Particles with Natural Anti-microbial Properties
  • 2005-351 Broad-spectrum Anti-microbial Peptide for the Treatment of Acne and Skin Cancer
  • 2001-194 Wit 3.0, a Novel Gene to Control Soft Tissue Wound Healing
  • 1997-505 A Protein of Mycobacterium Tuberculosis Stimulates Interleukin-12 Production
  • 1996-592 Cerberus and FRZB-1, Secretory Molecules with a Regenerative Function and an Inhibitory Activity on WNTS, Respectively

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    ENDOCRINE
  • 2012-065 Small Molecules for Islet Expansion in the Treatment of Diabetes
  • 2002-428 Polyphenolic Compounds Inhibit Pancreatic Cancer
  • 2002-427 Curcumin as a Treatment for Pancreatitis

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    GI
  • 2012-704 Peptide Treatment for Microbial Intestinal Inflammation
  • 2012-604 NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
  • 2012-129 NOVEL PROTOCOLS FOR ERADICATION OF H. PYLORI
  • 2011-293 A Novel Small Molecule Therapy to Prevent and Treat GI Inflammatory Diseases, Including GERD and Ulcers

  • | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    HEMATOLOGY
  • 2012-730 LENTIVIRAL VECTOR FOR STEM CELL GENE THERAPY OF SICKLE CELL DISEASE

  • | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    INFECTIOUS DISEASES
  • 2012-704 Peptide Treatment for Microbial Intestinal Inflammation
  • 2012-623 COMBINATION SHRNA VECTOR FOR HIV DISEASE
  • 2012-556 NOVEL METHODS FOR THE TREATMENT AND PREVENTION OF PERSISTANT VIRAL INFECTION
  • 2012-332 BIMODAL VACCINATION STRATEGY AGAINST TUBERCULOSIS
  • 2012-260 CHEMICAL COMPOUNDS THAT INHIBIT THE REPLICATION OF ENTEROVIRUSES AND OTHER PICORNAVIRUSES
  • 2012-259 A SMALL MOLECULE INHIBITOR OF MICROBIAL VIRULENCE FACTORS
  • 2012-029 Inhibition of Hepatitis C Virus Ns5a
  • 2011-562 Method for Manufacturing Potent Dendritic Cells
  • 2010-657 Novel Live Recombinant Booster Vaccine Against Tuberculosis
  • 2011-531 SMALL MOLECULES THAT MIMIC INTERFERON-GAMMA-MEDIATED ENDOTHELIAL CELL ACTIVATION
  • 2010-395 Molecules in Hops for the Treatment of Human Pathogenic Bacteria
  • 2010-079 Azuvirins: Novel Peptides with Potent Anti-cancer and Anti-viral Properties
  • 2009-666 Novel Small Molecules to Treat MRSA and Other Bacterial Infections
  • 2009-655 Safe and Potent Vaccines Against Tularemia
  • 2009-252 Anti-viral T-Cell Therapy from Stem Cells
  • 2009-055 HAPIVIRINS AND DIPROVIRINS NOVEL PEPTIDES ACTIVE AGAINST HIV1
  • 2009-002 ANTIMICROBIAL MESOPOROUS SILICA NANOPARTICLES
  • 2007-223 Novel Vaccines Against Tularemia
  • 2006-539 New Recombinant Tuberculosis BCG Vaccine for Immunocompromised Patients and Others
  • 2006-538 Recombinant Tuberculosis BCG Vaccine Elicits a Highly Protective Host Immune Response
  • 2006-264 Nano Particles with Natural Anti-microbial Properties
  • 2005-765 CYCLIC PEPTIDES HAVING BROAD SPECTRUM ANTIMICROBIAL ACTIVITY
  • 2004-046 Improved TB Vaccine Strategy Utilizing a Booster Protein for People Vaccinated with BCG
  • 2002-483 Novel Signaling Molecule Utilized By S. Mutans for Bio-film Formation and Quorum Sensing
  • 2002-427 Curcumin as a Treatment for Pancreatitis
  • 2001-329 Retrocyclin: an Anti-Retroviral Circular Minidefensin
  • 2000-313 NOVISPIRINS: ANTIMICROBIAL PEPTIDES ACTIVE AGAINST PSEUDOMONAS
  • 1999-556 HIV Protein Moderates Telomerase
  • 1998-560 LEPTOSPIRAL SURFACE-EXPOSED LIPOPROTEIN
  • 1997-505 A Protein of Mycobacterium Tuberculosis Stimulates Interleukin-12 Production
  • 1996-604 Targeted Prophylactic and Chemotherapeutic Agents Againstmycobacterium Tuberculosis
  • 1996-546 OUTER MEMBRANE ASSOCIATED PROTEINS OF LEPTOSPIRA SP
  • 1995-600 NOVEL PROTEGRIN-RELATED ANTIMICROBIAL PEPTIDES
  • 1995-579 Anti-Microbial Targeting for Intracellular Pathogens
  • 1995-565 LIPL2, A MEMBRANE LIPOPROTEIN OF LEPTOSPIRA KIRSCHNERI
  • 1994-518 Prophenins: Proline-Rich Antimicrobial Peptides with Repetitive Decamersequence
  • 1993-564 Novel Gene Therapy for AIDS Using Mutated tRNAs
  • 1993-540 PROTEGRINS: NOVEL MAMMALIAN ANTIBIOTIC PEPTIDES
  • 1992-529 A CLONED ANTIGEN FOR IMPROVED DETECTION AND PREVENTION OF LEPTOSPIROSIS
  • 1992-510 Immunoglobulin Superantigen Binding to GP120 from HIV
  • 1991-561 Restoration of Impaired Cellular Immune Function
  • 1991-543 Natural Killer Enhancing Factor

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    INFLAMMATORY
  • 2012-704 Peptide Treatment for Microbial Intestinal Inflammation
  • 2012-640 RECEPTOR INTERACTING PROTEIN 2 IN MODULATING INNATE AND ADAPTIVE IMMUNITY
  • 2012-140 A NOVEL APPROACH FOR ALLERGY THERAPEUTIC
  • 2011-875 Inhibition of a Macrophage-Specific Pathway to Treat Malignant Ascites
  • 2011-776 Small Molecule Suppressors of Immune Function
  • 2011-531 SMALL MOLECULES THAT MIMIC INTERFERON-GAMMA-MEDIATED ENDOTHELIAL CELL ACTIVATION
  • 2011-351 Novel Selective Inhibitors of Pro-Inflammatory Gene Expression for the Treatment of Inflammatory Conditions and Associated Screening Techniques
  • 2002-427 Curcumin as a Treatment for Pancreatitis
  • 1995-573 Use of Taxol in the Treatment of Rheumatoid Arthritis

  • | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    METABOLIC
  • 2012-065 Small Molecules for Islet Expansion in the Treatment of Diabetes
  • 2011-743 Regulation of Adipocyte Differentiation to Control Obesity
  • 2010-443 Small Molecule Treatment for Type 2 Diabetes
  • 2010-391 MITOCHONDRIA TREATMENT
  • 2010-008 SMALL MOLECULE MODULATORS OF ALKALINE PHOSPHATASE FUNCTION
  • 2009-720 Novel use of GABA to Treat Metabolic Syndrome, Type 2 Diabetes, and Other Related Diseases
  • 2008-210 Hypocretin (HCRT-1) Administration to Treat Narcolepsy and Obesity
  • 2005-604 Soluble and Cell-Associated Hemojuvelins as a Therapy and Diagnostic for Iron Metabolism Diseases

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    MUSCULOSKELETAL
  • 2011-061 Conversion of Normal Human Keratinocytes to Pluripotent Stem Cells for Treatment of Bone Loss
  • 2010-095 NOVEL OSTEOGENIC COMPOUNDS
  • 2008-483 Parathyroid Hormone (PTH) Supplement for Osteoporosis
  • 2007-145 Small Protein-mediated Therapy for the Treatment of Muscular Dystrophy
  • 1999-560 NELL-1 Protein with Activity in Bone Formation

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    NEUROLOGY
  • 2012-615 NEW COMPOUNDS FOR THE TREATMENT OF DISEASES RELATED TO PROTEIN MISFOLDING
  • 2012-180 A Novel Biomarker for Predicting Survival and Response to Treatment in Glioma
  • 2012-172 Nerve Agent Antidote Kit
  • 2011-742 Macrocyclic Inhibitors for Drug Design
  • 2011-741 Identification of Therapeutics for Parkinson's Disease and Other Neuropsychiatric Disorders using a Novel Functional Screen
  • 2011-329 New Use of Drug for Psychosis and Bipolar Disorder
  • 2011-294 Aminoacylase 3 (AA3) Inhibitors for the Prevention and Treatment of Alzheimer's and Parkinson's Disease
  • 2011-292 Pharmacophores for Amyloid Fibers Involved in Alzheimer’s Disease
  • 2011-101 Use of a Purified Flavonoid Compound to Prevent Fetal Alcohol Exposure-Induced Behavioral Disorders Including Adolescent Alcohol Abuse
  • 2011-063 Receptor Pathway and Potential Drug Target for Astrocyte Related Disorders of the Nervous System
  • 2010-472 Use of a Purified Flavonoid Compound to Prevent Alcohol Tolerance and Dependence
  • 2010-174 ANTIBODY-MEDICATED TRANSDUCTION OF HSP70 INTO LIVING CELLS
  • 2009-717 USE OF PYROGLUTAMYL-GLUTAMYL-PROLYL AMIDE (EEP) FOR NEUROLOGICAL AND NEUROBEHAVIORAL DISORDERS
  • 2009-626 VITAMIN D AND ALZHEIMER DISEASE
  • 2009-384 Novel Compounds for the Treatment of Essential Tremor
  • 2009-269 A Semi-synthetic Approach to the Production of Keppra
  • 2009-187 SELECTION OF E COLI WITH IMPROVED PROTEIN EXPRESSION
  • 2008-489 Small Molecule “Molecular Tweezers” that Inhibit Amyloid-β Fiber Formation
  • 2008-210 Hypocretin (HCRT-1) Administration to Treat Narcolepsy and Obesity
  • 2007-791 Estrogen Receptor Ligand Treatment for Neurodegenerative Diseases
  • 2004-598 Breakthrough Treatment for the Learning and Memory Deficiencies Associated with Neurofibromatosis Type 1
  • 2002-133 Use of a Gene and Related Mouse Model for the Study and Development of Therapeutics for Neuropsychiatric Disorders
  • 2000-236 Granulin as a Target for Tumor Diagnosis and Growth Regulation
  • 2000-128 Targeting Lentiviral Vectors to Specific Cells and Tissues
  • 2000-118 Modulation of Neuronal Outgrowth Through Agonism/Antagonism of the Major Histocompatibility Complex Class I (MHC I)
  • 1996-615 Mutations in Ataxia-Telangiectasia Gene
  • 1996-592 Cerberus and FRZB-1, Secretory Molecules with a Regenerative Function and an Inhibitory Activity on WNTS, Respectively
  • 1996-588 BROMOCRIPTINE IN THE TREATMENT OF ALCOHOLICS WITH THE A1 ALLELE OF DRD2
  • 1996-580 ALTERED REACTIVITY OF SUPEROXIDE DISMUTASE IN FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS
  • 1991-573 Cloned Vesicular Amine Transporters and Methods for Drug Screeningand Gene Therapy

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    ONCOLOGY
  • 2012-733 Novel Therapeutic Analogues of Metformin for the Treatment of Cancers
  • 2012-602 COMBINATION DRUG THERAPY FOR THE ACTIVATION OF EPIGENETICALLY SILENCED GENES
  • 2012-601 Novel Small Molecules that Target Cancer Stem Cells for the Treatment of Cancer
  • 2012-395 A NON-SURGICAL TREATMENT OF HUMAN CATARACTS
  • 2012-359 Drug Therapy for Prostate Cancer
  • 2012-220 TREATMENT OF BREAST CANCER WITH COMPANION DIAGNOSTIC
  • 2012-215 Small Molecule Read-through Compounds for Treating Genetic Diseases
  • 2011-875 Inhibition of a Macrophage-Specific Pathway to Treat Malignant Ascites
  • 2011-562 Method for Manufacturing Potent Dendritic Cells
  • 2011-531 SMALL MOLECULES THAT MIMIC INTERFERON-GAMMA-MEDIATED ENDOTHELIAL CELL ACTIVATION
  • 2011-417 A Small Molecule Inhibitor of Cholesterol Biosynthesis and Angiogenesis
  • 2011-017 NANOPARTICLE BASED siRNA/DRUG DELIVERY SYSTEM
  • 2011-011 A NEW TYPE OF NANODRUG FOR CANCER THERAPY
  • 2010-594 Antibody Fusion Proteins with Disrupted Heparin Binding Activity
  • 2010-272 Spp24: A Small Protein that Inhibits Tumor Growth in an Animal Model of Bone Metastasis
  • 2010-079 AZUVIRINS: NOVEL PEPTIDES WITH ANTIVIRAL AND ANTINEOPLASTIC POTENTIAL
  • 2009-677 NOVEL OXYSTEROLS THAT INHIBIT HEDGEHOG SIGNALING
  • 2009-591 INHIBITION OF TUMOR METASTASIS BY PROTEASOME INHIBITORS
  • 2008-738 Diagnostic and Therapeutic Utility of Cystatin E/M for Cervical Cancer
  • 2008-375 Enzyme-Driven Nanovalves for On-Demand Release of Guest Molecules
  • 2008-374 pH-Responsive Nanovalves
  • 2007-406 Protection Against Radiation
  • 2007-347 Use of Natural Killer (NK) Cells in Cancer Treatment
  • 2007-310 Improved Drug Delivery to Cancer Cells Using Modified Transferrin
  • 2006-357 Novel Non-peptidomimetic Prenyl Transferase Inhibitors
  • 2004-073 Murine PTEN Null Prostate Cancer Model
  • 2002-428 Polyphenolic Compounds Inhibit Pancreatic Cancer
  • 2002-422 A Method to Induce Anti-Viral Responses
  • 2001-381 Use of Secondary Lymphoid Organ Chemokine to Induce Anti-tumor Response by Stimulating Cell-mediated Immune Response and Inhibiting Angiogenesis
  • 2000-479 GDOX, A Novel Candidate Proto-oncogene
  • 2000-236 Granulin as a Target for Tumor Diagnosis and Growth Regulation
  • 1999-556 HIV Protein Moderates Telomerase
  • 1999-402 Diagnostic and Therapeutic Methods Using the H37 Tumor Suppressor Gene
  • 1998-556 GM-CSF and IL-4 Therapy for the In-Situ Expansion of Dendritic Cells and Enhancement of Vaccine-based Immunity
  • 1998-541 Specific Inhibitors of Cytokine Signaling
  • 1997-505 A Protein of Mycobacterium Tuberculosis Stimulates Interleukin-12 Production
  • 1996-615 Mutations in Ataxia-Telangiectasia Gene
  • 1996-569 TUMOR RADIOSENSITIZATION BY GENE THERAPY
  • 1993-581 MECHANISM OF INHIBITION OF CELL DEATH BY BCL-2
  • 1991-515 Method and Composition for Treatment of Kaposi's Sarcoma
  • 1990-544 REVERSIBLE ENHANCEMENT OF CELLULAR GROWTH

  • | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    OPHTHALMOLOGY
  • 2012-395 Non-Surgical Treatment of Cataracts

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    RESPIRATORY
  • 2007-105 Small Molecule Therapeutic for Treating Asthma and Other HIF1 Associated Conditions
  • 2000-377 Live Recombinant Tuberculosis Vaccine
  • 1999-402 Diagnostic and Therapeutic Methods Using the H37 Tumor Suppressor Gene

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    UROLOGICAL
  • 2004-084 Stemcell Urinary Tract Reconstruction therapy
  • 1996-525 Treatment of Polycystic Kidney Disease: Pharmacological Compounds and In-Vitro Screening System

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |


    OTHER
  • 2012-521 A PRENYLATED ANTHRACENONE POLYKETIDES AS AN IMMUNOSUPPRESSANT
  • 2012-516 SMALL MOLECULES TO COUNTER AGING AND AGE-RELATED DISEASES
  • 2012-340 A Novel Basic Fibroblast Growth Factor Conjugate for Broad Therapeutic Application
  • 2012-411 Device for the Treatment and Prevention of Radiation Induced Proctitis
  • 2012-292 ORGAN RESUSCITATION SOLUTION AND SYSTEM FOR ENHANCED LIVER TRANSPLANTATION
  • 2010-504 INHIBITION OF HAIR GROWTH
  • 2010-391 MITOCHONDRIA TREATMENT
  • 2010-043 METHODS FOR DYNAMIC MODIFICATION OF LOCALIZED CELLULAR ENVIRONMENTS
  • 2009-381 IDENTIFICATION OF SMALL MOLECULES THAT FACILITATE THERAPEUTIC EXON SKIPPING
  • 2008-693 New Use of a Pharmaceutical to treat Snoring, Sleep Apnea and Related Disorders
  • 2008-210 Hypocretin (HCRT-1) Administration to Treat Narcolepsy and Obesity
  • 2006-584 Drug for Dialysis-related Amyloidosis
  • 2004-675 An Intelligent Nanomedicine Integrating Diagnosis and Therapy
  • 2004-522 Compounds for Treating Microbial Infections in the Oral Cavity, for Incorporating into Consumer Oral Health Products

    | BACK TO SEARCH-TECHS | TOP OF PAGE | CONTACT |




    SEARCH by Case Number, Inventor Name, and/or Keywords:
    Loading
  •  
    UCLA
    Technology
    Commercialization
    Opportunities



    All Categories
    All LifeSci Tech
    All PhySci Tech

    The Office of Intellectual Property (OIP) manages the invention and patent portfolio resulting from UCLA research funded by more than $950 million per year in federal, state and private contracts and grants.

    Office Address:

    Office of Intellectual Property
    11000 Kinross Ave., Suite 200
    Los Angeles, CA 90095-7231
    Tel. 310.794.0558

    http://www.oip.ucla.edu/
    ncd@research.ucla.edu




    Inside the Lab @ UCLA




    :: UCLA Research Interests
    :: UCLA Lab Directory
    :: UCLA Invents



    :: Campus Directory
    :: UCLA main research page
    :: UCLA Home Page
    :: About UCLA



    Copyright © 2013 The Regents of the University of California